A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...

The cancer diagnostics market was valued at $168,600.04 million in 2020, and is projected to reach $280,590.21 million by 2028, registering a CAGR of 6.9% from 2021 to 2028. The major factor that ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

However, the specific influence of nutritional markers on ovarian cancer prognosis remains inadequately studied ... The demographic and clinical characteristics of both groups were summarized in Table ...

Ash, 26, showing the large ovarian tumor she developed before having it removed in November 2024. Ash, 26, showing the large ovarian tumor she developed before having it removed in November 2024.

These markers are highly expressed in CAFs in ovarian cancer stroma ... making the treatment of ovarian cancer targeting CAFs widely used in clinical practice (Table 2). Cancer-associated fibroblasts ...

a novel population of myeloid cells abundant in ovarian cancer and critical for tumor angiogenesis. Surprisingly, St Croix et al. identified 46 genes, initially termed tumor endothelial markers ...

Your doctor’s interpretation of your results depends on the tumor markers they see. The table below provides some examples of blood tumor markers and how they’re used. Note that it’s not ...